Mutation Analysis of BRCA1, TP53, and KRAS2 in Ovarian and Related Pelvic Tumors
- 1 July 1999
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 112 (2) , 105-118
- https://doi.org/10.1016/s0165-4608(98)00267-2
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutationNature Genetics, 1997
- Analysis of loss of heterozygosity andKRAS2 mutations in ovarian neoplasms: Clinicopathological correlationsGenes, Chromosomes and Cancer, 1997
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Distinct transcription start sites generate two forms of BRCA1 mRNAHuman Molecular Genetics, 1995
- Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1Human Molecular Genetics, 1993
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990
- The genetic origins of human cancerCancer, 1988
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971